A Standardized Measurement and Valuation Scale of Genomic Utility for Policy Decisions: The GUV Scale
Comparisons of genomic utility across different clinical contexts may seem difficult because of the multiple criteria required to be weighted to support policy decisions. This comparison is now facilitated in a standardized manner with the GUV scale.
Authors
- Zoe Fehlberg (ORCID: https://orcid.org/0000-0002-8449-206X)
- Andrew John Mallett (ORCID: https://orcid.org/0000-0002-8752-2551)
- Ilias Goranitis (ORCID: https://orcid.org/0000-0001-7946-8324)
- D.R. Sheen (ORCID: https://orcid.org/0000-0003-0507-4001)
- Zornitza Stark (ORCID: https://orcid.org/0000-0001-8640-1371)
- Stephanie Best (ORCID: https://orcid.org/0000-0002-1107-8976)
Institutions
- The University of Queensland (AU)
- The University of Melbourne (AU)
- Peter MacCallum Cancer Centre (AU)
- Victorian Clinical Genetics Services (AU)
- Melbourne Health (AU)
- Melbourne Genomics Health Alliance (AU)
Publication Details
- Journal
- Value in Health
- Published
- 2024-12-24
- DOI
- https://doi.org/10.1016/j.jval.2024.11.014
- Citations
- 8
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 9.03
Funders
- Australian Government
- Medical Research Council
- National Health and Medical Research Council